fintopic.
Docs Get the API

Moberg Pharma reports losses for nine months

6 statements from 2 sources on Nov 12, 2026, 07:00–07:46 UTC
News
Updated
Front page

Statements (6)

  1. Bearish

    Moberg Pharma reported a net loss of 1.7 million kronor after tax for the third quarter of 2026.

    di.se
  2. Bearish

    Moberg Pharma reported EBITDA of SEK -8.5 million for the period from January to September 2026.

    news.cision.com
  3. Bearish

    Moberg Pharma reported diluted earnings per share of SEK -0.13 for the period from January to September 2026.

    news.cision.com
  4. Neutral

    Moberg Pharma reported net revenue of SEK 16.5 million for the period from January to September 2026.

    news.cision.com
  5. Bearish

    Moberg Pharma reported operating profit (EBIT) of SEK -9.8 million for the period from January to September 2026.

    news.cision.com
  6. Bearish

    Moberg Pharma reported profit for the period of SEK -6.3 million for the period from January to September 2026.

    news.cision.com